- Advanced search
- Immuno Portal
- Malaria Portal
Synonyms: REGN475 | SAR164877
Compound class: Antibody
Comment: Fasinumab is an investigational, fully human IgG4κ monoclonal antibody targeting nerve growth factor (NGF).
Peptide sequence information for this antibody is available from its IMGT/mAb-DB record.
BLAST peptide sequence analysis reveals identical matches to peptide sequences submitted with patent US7988967 , with the preferred antibody being called REGN475 therein. REGN475 exhibits high specificity for human NGF, does not cross-react with closely related neurotrophin-3 (NT-3) and inhibits binding of NGF to its receptors TrkA (NTRK1) and p75 (NGFR) .
|International Nonproprietary Names|
|REGN475 | SAR164877|
|GtoPdb PubChem SID||310264745|
|Search PubMed clinical trials||fasinumab|
|Search PubMed titles||fasinumab|
|Search PubMed titles/abstracts||fasinumab|